G. Ravn-Haren et al., in a case-control study of a Danish population of women, observed that patients with the CT or TT genotype of the GPX1 (rs1050450) gene had a 1.43 times higher risk of breast cancer compared to patients with the CC genotype [14]. This evidence concerns the gene GPX1 and breast carcinoma.